These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
43. [C-reactive protein (CRP) as a marker of of hemodialysis biocompatibility]. Szepietowski T; Krajewska M Polim Med; 1997; 27(1-2):47-59. PubMed ID: 9380601 [TBL] [Abstract][Full Text] [Related]
44. AN69-ST membrane, a useful option in two cases of severe dialysis reactions. Cerqueira A; Martins PA; Carvalho BA; Vasconcelos MP Clin Nephrol; 2015 Feb; 83(2):100-3. PubMed ID: 25208312 [TBL] [Abstract][Full Text] [Related]
45. Clinical impact of biocompatible dialysis membranes on patient morbidity and mortality: an appraisal of the evidence. Churchill DN Nephrol Dial Transplant; 1995; 10 Suppl 10():52-6. PubMed ID: 8825434 [No Abstract] [Full Text] [Related]
46. New trends in membrane development. von Sengbusch G Contrib Nephrol; 1989; 70():250-9. PubMed ID: 2766737 [No Abstract] [Full Text] [Related]
47. Haemodialysis membranes: a matter of fact or taste? Hoenich NA; Katopodis KP Contrib Nephrol; 2001; (133):81-104. PubMed ID: 11477756 [No Abstract] [Full Text] [Related]
49. Efficacy of choice of dialysis membrane. Koda Y; Suzuki M; Hirasawa Y Nephrol Dial Transplant; 2001; 16 Suppl 4():23-6. PubMed ID: 11402093 [No Abstract] [Full Text] [Related]
50. The effect of dialysis environment on the mechanical behaviour of hollow polymeric fibers. Konduk BA; Ucisik AH Med J Malaysia; 2004 May; 59 Suppl B():53-4. PubMed ID: 15468815 [TBL] [Abstract][Full Text] [Related]
51. Effect of membrane composition and structure on solute removal and biocompatibility in hemodialysis. Clark WR; Hamburger RJ; Lysaght MJ Kidney Int; 1999 Dec; 56(6):2005-15. PubMed ID: 10594776 [TBL] [Abstract][Full Text] [Related]
52. [The effect of the primary and repeated use of dialyzers with different membranes on the degree of dialysis-induced leukopenia]. Strokov AG; Baeva LB; Levitskiĭ ER Med Tekh; 1990; (5):16-8. PubMed ID: 2273963 [TBL] [Abstract][Full Text] [Related]
57. Are biocompatible membranes superior for hemodialysis therapy? van Ypersele de Strihou C Kidney Int Suppl; 1997 Nov; 62():S101-4. PubMed ID: 9350694 [No Abstract] [Full Text] [Related]
58. Biocompatibility and functional performance of a polyethylene glycol acid-grafted cellulosic membrane for hemodialysis. Sirolli V; Di Stante S; Stuard S; Di Liberato L; Amoroso L; Cappelli P; Bonomini M Int J Artif Organs; 2000 Jun; 23(6):356-64. PubMed ID: 10919752 [TBL] [Abstract][Full Text] [Related]
59. Clinical manifestations of AB-amyloidosis: effects of biocompatibility and flux. Schiffl H; Fischer R; Lang SM; Mangel E Nephrol Dial Transplant; 2000 Jun; 15(6):840-5. PubMed ID: 10831638 [TBL] [Abstract][Full Text] [Related]
60. Leukocyte adhesion molecules and leukocyte-platelet interactions during hemodialysis: effects of different synthetic membranes. Sirolli V; Ballone E; Amoroso L; Di Liberato L; Di Mascio R; Capelli P; Albertazzi A; Bonomini M Int J Artif Organs; 1999 Aug; 22(8):536-42. PubMed ID: 10533909 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]